Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 344

2.

Myxoid/round cell and pleomorphic liposarcomas: prognostic factors and survival in a series of patients treated at a single institution.

Fiore M, Grosso F, Lo Vullo S, Pennacchioli E, Stacchiotti S, Ferrari A, Collini P, Lozza L, Mariani L, Casali PG, Gronchi A.

Cancer. 2007 Jun 15;109(12):2522-31.

3.

Clinicopathologic prognostic factors in myxoid liposarcoma: a retrospective study of 49 patients with long-term follow-up.

ten Heuvel SE, Hoekstra HJ, van Ginkel RJ, Bastiaannet E, Suurmeijer AJ.

Ann Surg Oncol. 2007 Jan;14(1):222-9. Epub 2006 Oct 22.

PMID:
17058128
4.

The association between tumour progression and vascularity in myxofibrosarcoma and myxoid/round cell liposarcoma.

Mentzel T, Brown LF, Dvorak HF, Kuhnen C, Stiller KJ, Katenkamp D, Fletcher CD.

Virchows Arch. 2001 Jan;438(1):13-22.

PMID:
11213831
6.

Pleomorphic liposarcoma: clinicopathologic, immunohistochemical, and follow-up analysis of 63 cases: a study from the French Federation of Cancer Centers Sarcoma Group.

Gebhard S, Coindre JM, Michels JJ, Terrier P, Bertrand G, Trassard M, Taylor S, Château MC, Marquès B, Picot V, Guillou L.

Am J Surg Pathol. 2002 May;26(5):601-16.

PMID:
11979090
7.

The clinicopathologic spectrum of myxoid and round cell liposarcoma. A study of 95 cases.

Kilpatrick SE, Doyon J, Choong PF, Sim FH, Nascimento AG.

Cancer. 1996 Apr 15;77(8):1450-8.

9.

Paratesticular liposarcoma: a clinicopathologic study.

Montgomery E, Fisher C.

Am J Surg Pathol. 2003 Jan;27(1):40-7.

PMID:
12502926
10.

Lipomatous tumors.

Weiss SW.

Monogr Pathol. 1996;38:207-39. Review.

PMID:
8744279
11.

Radiosensitivity translates into excellent local control in extremity myxoid liposarcoma: a comparison with other soft tissue sarcomas.

Chung PW, Deheshi BM, Ferguson PC, Wunder JS, Griffin AM, Catton CN, Bell RS, White LM, Kandel RA, O'Sullivan B.

Cancer. 2009 Jul 15;115(14):3254-61. doi: 10.1002/cncr.24375.

12.

Clinicopathologic prognostic factors of pure myxoid liposarcoma of the extremities and trunk wall.

Nishida Y, Tsukushi S, Nakashima H, Ishiguro N.

Clin Orthop Relat Res. 2010 Nov;468(11):3041-6. doi: 10.1007/s11999-010-1396-3.

14.
15.
16.

Dedifferentiated liposarcoma of retroperitoneum and mesentery: varied growth patterns and histological grades--a clinicopathologic study of 32 cases.

Hasegawa T, Seki K, Hasegawa F, Matsuno Y, Shimodo T, Hirose T, Sano T, Hirohashi S.

Hum Pathol. 2000 Jun;31(6):717-27.

PMID:
10872666
17.

Patterns of recurrence in extremity liposarcoma: implications for staging and follow-up.

Pearlstone DB, Pisters PW, Bold RJ, Feig BW, Hunt KK, Yasko AW, Patel S, Pollack A, Benjamin RS, Pollock RE.

Cancer. 1999 Jan 1;85(1):85-92.

PMID:
9921978
18.

Prognostic impact of P53 status, TLS-CHOP fusion transcript structure, and histological grade in myxoid liposarcoma: a molecular and clinicopathologic study of 82 cases.

Antonescu CR, Tschernyavsky SJ, Decuseara R, Leung DH, Woodruff JM, Brennan MF, Bridge JA, Neff JR, Goldblum JR, Ladanyi M.

Clin Cancer Res. 2001 Dec;7(12):3977-87.

19.

Liposarcomas in young patients: a study of 82 cases occurring in patients younger than 22 years of age.

Alaggio R, Coffin CM, Weiss SW, Bridge JA, Issakov J, Oliveira AM, Folpe AL.

Am J Surg Pathol. 2009 May;33(5):645-58. doi: 10.1097/PAS.0b013e3181963c9c.

PMID:
19194281
20.

Atypical and malignant neoplasms showing lipomatous differentiation. A study of 111 cases.

Azumi N, Curtis J, Kempson RL, Hendrickson MR.

Am J Surg Pathol. 1987 Mar;11(3):161-83.

PMID:
3826477

Supplemental Content

Support Center